XOMA (XOMA Royalty) Cyclically Adjusted Revenue per Share: $2.06 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XOMA XOMA Royalty Corp XOMA
41 GF Score
Price $40.17
GF Value $18.96
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is XOMA Royalty Cyclically Adjusted Revenue per Share?

XOMA Royalty XOMA -0.10% 41 Cyclically Adjusted Revenue per Share is $2.06 as of Mar. 2026. GuruFocus rates XOMA with a GF Score™ of 41/100 and a GF Value™ of $18.96 (Significantly Overvalued). The stock has 8 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

XOMA Royalty's adjusted revenue per share for the three months ended in Mar. 2026 was $0.018. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $2.06 for the trailing ten years ended in Mar. 2026.

During the past 12 months, XOMA Royalty's average Cyclically Adjusted Revenue Growth Rate was -36.40% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was -21.60% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was -22.90% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was -32.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of XOMA Royalty was 12.60% per year. The lowest was -45.50% per year. And the median was -8.05% per year.

As of today (2026-07-27), XOMA Royalty's current stock price is $40.17. XOMA Royalty's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was $2.06. XOMA Royalty's Cyclically Adjusted PS Ratio of today is 19.50.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of XOMA Royalty was 21.47. The lowest was 0.06. And the median was 3.80.


XOMA Royalty  (NAS:XOMA) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

XOMA Royalty's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=40.17/2.06
=19.50

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of XOMA Royalty was 21.47. The lowest was 0.06. And the median was 3.80.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


XOMA Royalty Cyclically Adjusted Revenue per Share Related Terms


XOMA Royalty Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for XOMA Royalty's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

XOMA Royalty Cyclically Adjusted Revenue per Share Chart

XOMA Royalty Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.42 4.38 3.50 3.23 2.11

XOMA Royalty Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.24 3.24 3.22 2.11 2.06

XOMA vs STTK, OMER, BBOT: Cyclically Adjusted Revenue per Share Comparison

For the Biotechnology subindustry, XOMA Royalty's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


XOMA Royalty Cyclically Adjusted PS Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, XOMA Royalty's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where XOMA Royalty's Cyclically Adjusted PS Ratio falls into.


XOMA
41GF Score
XOMA Royalty Corp XOMA
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

XOMA Royalty Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, XOMA Royalty's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.018/330.2130*330.2130
=0.018

Current CPI (Mar. 2026) = 330.2130.

XOMA Royalty Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 0.074 241.018 0.101
201609 0.105 241.428 0.144
201612 0.087 241.432 0.119
201703 0.038 243.801 0.051
201706 1.425 244.955 1.921
201709 4.373 246.819 5.851
201712 0.591 246.524 0.792
201803 0.056 249.554 0.074
201806 0.270 251.989 0.354
201809 0.107 252.439 0.140
201812 0.200 251.233 0.263
201903 0.872 254.202 1.133
201906 0.110 256.143 0.142
201909 0.938 256.759 1.206
201912 0.047 256.974 0.060
202003 0.082 258.115 0.105
202006 0.041 257.797 0.053
202009 0.051 260.280 0.065
202012 1.915 260.474 2.428
202103 0.033 264.877 0.041
202106 0.080 271.696 0.097
202109 0.083 274.310 0.100
202112 2.407 278.802 2.851
202203 0.274 287.504 0.315
202206 0.086 296.311 0.096
202209 0.039 296.808 0.043
202212 0.130 296.797 0.145
202303 0.038 301.836 0.042
202306 0.145 305.109 0.157
202309 0.072 307.789 0.077
202312 0.160 306.746 0.172
202403 0.129 312.332 0.136
202406 0.326 314.175 0.343
202409 0.063 315.301 0.066
202412 0.197 315.605 0.206
202503 0.243 319.799 0.251
202506 0.303 322.561 0.310
202509 0.029 324.800 0.029
202512 0.079 324.054 0.081
202603 0.018 330.213 0.018

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of $2.06 mean?
XOMA Royalty (XOMA) has a Cyclically Adjusted Revenue per Share of $2.06 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on XOMA Royalty and its competitors.
Is XOMA Royalty's Cyclically Adjusted Revenue per Share too high?
XOMA Royalty's current Cyclically Adjusted Revenue per Share is $2.06. Overall, XOMA Royalty has a GF Score™ of 41/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does XOMA Royalty's Cyclically Adjusted Revenue per Share compare to STTK and OMER?
XOMA Royalty's Cyclically Adjusted Revenue per Share of $2.06 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Biotechnology company?
A good Cyclically Adjusted Revenue per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on XOMA Royalty and its competitors. XOMA Royalty's current Cyclically Adjusted Revenue per Share is $2.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is XOMA Royalty stock overvalued right now?
Based on GuruFocus' analysis, XOMA Royalty (XOMA) is currently considered Significantly Overvalued. The stock's GF Value™ is $18.96, compared to a current price of $40.17 — trading 111.9% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is $2.06. XOMA Royalty's overall GF Score™ is 41/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For XOMA Royalty (XOMA), the current Cyclically Adjusted Revenue per Share is $2.06 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is XOMA Royalty (XOMA) Overvalued in 2026?

Based on GuruFocus' analysis, XOMA Royalty stock appears to be overvalued. The current stock price of $40.17 is trading 111.9% above its estimated GF Value™ of $18.96. GuruFocus considers XOMA Royalty to be Significantly Overvalued.

Key valuation signals for XOMA:

  • Cyclically Adjusted Revenue per Share: $2.06
  • GF Value™: $18.96 vs. price of $40.17 (111.9% above fair value)
  • GF Score™: 41/100 with 8 warning signs

No single metric tells the full story. See the XOMA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


XOMA Royalty Business Description

Address 2200 Powell Street, Suite 310, Emeryville, CA, USA, 94608
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates. The Company's drug royalty aggregator business is mainly focused on the acquisition of early to mid-stage clinical assets. Geographically, the company operates in Switzerland, the United States, Asia Pacific, Europe, and other regions.
41GF Score

Get the complete analysis for XOMA

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$40.17
Price
$18.96
GF Value